LeMaitre Vascular Files 8-K on Shareholder Vote Matters
Ticker: LMAT · Form: 8-K · Filed: Jun 3, 2025 · CIK: 1158895
| Field | Detail |
|---|---|
| Company | Lemaitre Vascular Inc (LMAT) |
| Form Type | 8-K |
| Filed Date | Jun 3, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-vote
Related Tickers: LMAT
TL;DR
LMAT filing 8-K: Shareholder vote matters on the table.
AI Summary
On June 2, 2025, LeMaitre Vascular, Inc. filed an 8-K report indicating that it is submitting matters to a vote of its security holders. The filing was made on June 3, 2025, and pertains to the company's corporate governance and shareholder decisions.
Why It Matters
This filing signals that important decisions requiring shareholder approval are being presented, which could impact the company's future direction and governance.
Risk Assessment
Risk Level: low — The filing is procedural, related to submitting matters for a shareholder vote, and does not disclose new financial or operational risks.
Key Players & Entities
- LeMaitre Vascular, Inc. (company) — Registrant
- June 2, 2025 (date) — Date of earliest event reported
- June 3, 2025 (date) — Filing date
- 001-33092 (company) — SEC File Number
- 63 Second Avenue, Burlington, Massachusetts (location) — Principal Executive Offices
FAQ
What specific matters are being submitted to a vote of LeMaitre Vascular's security holders?
The provided text of the 8-K filing does not specify the exact matters being submitted for a vote; it only states that such matters are being presented.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on June 2, 2025.
What is LeMaitre Vascular, Inc.'s principal executive office address?
LeMaitre Vascular, Inc.'s principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts.
What is the SEC file number for LeMaitre Vascular, Inc.?
The SEC file number for LeMaitre Vascular, Inc. is 001-33092.
What is the filing date of this 8-K report?
This 8-K report was filed on June 3, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on June 3, 2025 regarding LEMAITRE VASCULAR INC (LMAT).